Rangaramanujam Kannan - Search Results

Year	Number of Results
2003	2
2004	2
2005	2
2006	2
2007	1
2008	3
2009	5
2010	11
2011	6
2012	4
2013	9
2014	3
2015	9
2016	8
2017	10
2018	12
2019	2
2020	14
2021	13
2022	6

1

Editorial.

Hanes J, Ensign L, Kannan R, Suk JS. Hanes J, et al. Among authors: kannan r. J Control Release. 2015 Dec 10;219:1. doi: 10.1016/j.jconrel.2015.10.057. J Control Release. 2015. PMID: 26590704 No abstract available.

2

Nanomedicine in cerebral palsy.

Balakrishnan B, Nance E, Johnston MV, Kannan R, Kannan S. Balakrishnan B, et al. Among authors: kannan r. Int J Nanomedicine. 2013;8:4183-95. doi: 10.2147/IJN.S35979. Epub 2013 Nov 1. Int J Nanomedicine. 2013. PMID: 24204146 Free PMC article. Review.

3

Nanotechnology enabled regenerative medicine for neurological disorders.

Lowe TL, Agrahari V, Kannan RM, Kannan S. Lowe TL, et al. Among authors: kannan rm. Adv Drug Deliv Rev. 2019 Aug;148:1-2. doi: 10.1016/j.addr.2019.11.006. Adv Drug Deliv Rev. 2019. PMID: 31787167 Free PMC article. No abstract available.

4

Emerging nanomedicine approaches in obstetrics.

Kannan RM, Kannan S. Kannan RM, et al. Am J Obstet Gynecol. 2017 Mar;216(3):201-203. doi: 10.1016/j.ajog.2017.01.038. Am J Obstet Gynecol. 2017. PMID: 28249659 No abstract available.

5

Nanotechnology approaches for ocular drug delivery.

Xu Q, Kambhampati SP, Kannan RM. Xu Q, et al. Among authors: kannan rm. Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):26-37. doi: 10.4103/0974-9233.106384. Middle East Afr J Ophthalmol. 2013. PMID: 23580849 Free PMC article. Review.

6

Dendrimer nanoparticles for ocular drug delivery.

Kambhampati SP, Kannan RM. Kambhampati SP, et al. Among authors: kannan rm. J Ocul Pharmacol Ther. 2013 Mar;29(2):151-65. doi: 10.1089/jop.2012.0232. Epub 2013 Feb 14. J Ocul Pharmacol Ther. 2013. PMID: 23410062 Review.

7

Targeted drug delivery for maternal and perinatal health: Challenges and opportunities.

Sharma A, Sah N, Kannan S, Kannan RM. Sharma A, et al. Among authors: kannan rm. Adv Drug Deliv Rev. 2021 Oct;177:113950. doi: 10.1016/j.addr.2021.113950. Epub 2021 Aug 26. Adv Drug Deliv Rev. 2021. PMID: 34454979 Review.

8

Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.

Turk BR, Nemeth CL, Marx JS, Tiffany C, Jones R, Theisen B, Kambhampati S, Ramireddy R, Singh S, Rosen M, Kaufman ML, Murray CF, Watkins PA, Kannan S, Kannan R, Fatemi A. Turk BR, et al. Among authors: kannan r. Ann Neurol. 2018 Sep;84(3):452-462. doi: 10.1002/ana.25303. Ann Neurol. 2018. PMID: 30069915 Free PMC article.

9

Dendrimer-tesaglitazar conjugate induces a phenotype shift of microglia and enhances β-amyloid phagocytosis.

DeRidder L, Sharma A, Liaw K, Sharma R, John J, Kannan S, Kannan RM. DeRidder L, et al. Among authors: kannan rm. Nanoscale. 2021 Jan 21;13(2):939-952. doi: 10.1039/d0nr05958g. Nanoscale. 2021. PMID: 33479718

10

Dendrimer-Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy.

Cho H, Kambhampati SP, Lai MJ, Zhou L, Lee G, Xie Y, Hui Q, Kannan RM, Duh EJ. Cho H, et al. Among authors: kannan rm. Adv Ther (Weinh). 2021 Feb;4(2):2000181. doi: 10.1002/adtp.202000181. Epub 2020 Nov 9. Adv Ther (Weinh). 2021. PMID: 34527806 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results